Yes, there are several FDA-approved medications for ADHD, and they are among the most effective treatments in psychiatry. The two main categories are stimulants and non-stimulants, and most people start with a stimulant because they tend to work faster and for a larger percentage of patients. Medication is often combined with behavioral strategies for the best results, especially in children.
Stimulant Medications
Stimulants are the most widely prescribed ADHD medications. They work by increasing the activity of certain brain chemicals involved in focus, impulse control, and attention. Despite the name, they don’t make people with ADHD “more stimulated.” They help the brain’s attention system function more consistently, which often makes people feel calmer and more organized.
There are two main families of stimulants:
- Methylphenidate-based: includes brand names like Ritalin, Concerta, Metadate CD, Focalin, and Relexxii
- Amphetamine-based: includes Adderall, Adderall XR, Vyvanse, and Dexedrine
If one family doesn’t work well or causes too many side effects, switching to the other often helps. The two types affect brain chemistry in slightly different ways, so a poor response to one doesn’t mean the other will fail too.
Short-Acting vs. Long-Acting Formulations
Stimulants come in immediate-release and extended-release versions, and the difference matters for daily life. Immediate-release tablets are the least expensive option, with generic methylphenidate starting around $8 to $10 for a month’s supply. They wear off relatively quickly, so they may need to be taken two or three times a day.
Extended-release versions last much longer and only need to be taken once in the morning. Depending on the specific product, coverage ranges from about 8 hours up to 12 hours. Concerta, Adderall XR, Focalin XR, and Vyvanse all provide roughly 10 to 12 hours of coverage. Some people add a small immediate-release dose in the late afternoon if they need focus into the evening. Extended-release formulations cost more, with generic versions starting around $40 for a month and brand-name or specialized forms running significantly higher.
Non-Stimulant Medications
The FDA has approved four non-stimulant medications for ADHD: atomoxetine (Strattera), guanfacine (Intuniv), clonidine (Kapvay), and viloxazine (Qelbree). These are typically considered when stimulants cause intolerable side effects, when someone has a condition that makes stimulants risky (like certain heart problems or a history of substance misuse), or when a person simply prefers a non-controlled medication.
Non-stimulants generally take longer to reach full effect, sometimes several weeks, compared to stimulants that often work within the first day or two. Atomoxetine provides 10 to 12 hours of coverage and can be a good option for people who also have anxiety, since stimulants sometimes worsen it. Guanfacine and clonidine were originally developed as blood pressure medications and can cause drowsiness, which is sometimes helpful for children who struggle with sleep.
Treatment Differences by Age
For young children between ages 4 and 6, the CDC recommends starting with behavioral approaches first, specifically parent training in behavior management and classroom interventions. Medication at this age is generally reserved for cases where behavioral strategies alone haven’t made enough of a difference, and methylphenidate is the preferred option if medication becomes necessary.
For children 6 and older, adolescents, and adults, FDA-approved medications are a standard first-line treatment, often alongside behavioral strategies. The prescriber typically starts at a low dose and adjusts upward gradually, looking for the point where symptoms improve the most with the fewest side effects. For adolescents, guidelines emphasize that the teen should agree to taking the medication, not just the parents.
Common Side Effects
The most frequent side effect of stimulant medications is decreased appetite, which affects roughly 80% of people who take them. This often leads to some weight loss, particularly in the first few months. Many people manage this by eating a solid breakfast before the medication kicks in and having a larger meal in the evening when it wears off.
Sleep difficulty is also common. Stimulants can make it harder to fall asleep and reduce overall sleep quality, which is why timing the dose earlier in the day matters. Other possible effects include upset stomach, mild increases in heart rate or blood pressure, and a “rebound” period of irritability or fatigue as the medication wears off at the end of the day.
Some children develop tics, like eye blinking or throat clearing, though these often resolve if the dose is lowered or the medication is changed. Parents sometimes worry about growth. Stimulants can cause a minor slowdown in growth rate during the first year or two, but research indicates it doesn’t affect final adult height.
Long-Term Cardiovascular Considerations
Because stimulants increase heart rate and blood pressure slightly, there has been ongoing interest in whether years of use affect heart health. A large study published in the Journal of the American College of Cardiology found that adults taking stimulants over many years had a modestly higher risk of stroke and heart failure compared to those who had stopped treatment. The 10-year risk of stroke was 2.1% for current users versus 1.7% for prior users, and heart failure risk was 1.2% versus 0.7%. The risk appeared to increase with higher doses and longer use.
These are small absolute numbers, and for most people the benefits of treating ADHD outweigh this risk. But it does mean that people on long-term stimulant therapy should have their blood pressure and heart rate monitored periodically, and anyone with pre-existing heart conditions should discuss this carefully with their prescriber before starting.
Finding the Right Medication
There is no blood test or brain scan that predicts which ADHD medication will work best for a specific person. The process is trial and adjustment. Most prescribers start with a low dose of a stimulant, observe for a few weeks, and make changes based on how well symptoms improve and what side effects appear. If the first medication isn’t a good fit, switching to a different one within the same class, or to the other stimulant family, or to a non-stimulant is completely normal.
Generic versions of most major ADHD medications are available, which can make a significant cost difference. Brand-name extended-release formulations and newer medications like Qelbree tend to be more expensive, and insurance coverage varies widely. If cost is a barrier, starting with generic immediate-release methylphenidate or amphetamine salts is a reasonable and effective first step.